Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Startups & Unicorns companies in Nicotinamide mononucleotide
by Most News Heat in the world in 2021

The Nicotinamide mononucleotide top 5 is Discovery PatSnap’ annual ranking of the top 5 Most News Heat Nicotinamide mononucleotide Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).

Key Players

Fast-growings

Startups & Unicorns

New Entrants

Ranking Year:

2022

2021

Region:

Global

Ranking:

Most News Heat

#
Company Name
Region
Tech Topics
Total
1
ExcelVite Sdn. Bhd.
Perak, Malaysia
Carotenoid,Medicine,Feed additive,
...[+2]
news: 1
2
FSP Consulting Services Ltd.
Manchester, United Kingdom
Digital transformation
news: 1
3
Nature, Inc.
Kanagawa, Japan
Composite material,Internet of Things,Remote control,
...[+1]
news: 1
4
Goji Investments
United Kingdom
Peer-to-peer,Venture capital
news: 1
5
Extract Co.
Delaware, United States
Software,Metrics,Information technology consulting,
...[+2]
news: 1

Who we serve

R&D Decision MakersNew Product Innovation LeaderTechnology Research AnalystsBusiness Development Professionals

Why Discovery

Technology Intelligence Data FoundationAI-powered Competitive Intelligence RadarTechnology Classification and Company Innovation Indicators

Social media

Try Discovery

Free Trial
PatSnap group products
Browse By:ABCDEFGHIJKLMNOPQRSTUVWXYZ#All topics,List of companies,Sitemap
© 2023 PatSnap. All rights reserved.Legal | Privacy policy Modern Slavery Act Transparency Statement
Page generation time: Jun 17 2025
For better visiting experience, please use PC device.X